Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The glass ionomer polyacid–glass matrix is the structural foundation of glass ionomer cements (GICs), which are widely used in restorative dentistry [1]. These materials are formed through an acid-base reaction between a polymeric acid, such as polyacrylic acid, and a basic fluoroaluminosilicate glass powder [2]. The resulting matrix consists of unreacted glass cores embedded in a silica gel and a metal-polyacrylate cross-linked hydrogel [3]. GICs are valued for their ability to chemically bond to tooth structure (enamel and dentin) and their sustained release of fluoride, which provides anticariogenic properties [1]. While they are biocompatible and have a coefficient of thermal expansion similar to tooth structure, they generally possess lower fracture toughness and wear resistance compared to resin-based composites [2][3].
The matrix forms through an acid-base reaction where polyalkenoic acid chains are cross-linked by calcium and aluminum ions released from fluoroaluminosilicate glass particles [1][2]. This process creates a chemically bonded interface with the tooth's hydroxyapatite [3].
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glass ionomer cement (GIC) (GIC).